Dr. Wadhwa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 E Michigan Ave
Ste 105
Jackson, MI 49201Phone+1 517-782-3190Fax+1 517-782-1223
Summary
- Dr. Anish Wadhwa is a pulmonary/critical care specialist in Jackson, MI and is affiliated with multiple hospitals in the area, including Henry Ford Allegiance Health and Hillsdale Hospital. He received his medical degree from the University of Cincinnati College of Medicine, completed training in Internal Medicine at CWRU-University Hospitals of Cleveland, also fellowship training at Michigan Medicine. He specializes in pulmonary, critical care, and sleep medicine.
Education & Training
University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Cincinnati College of MedicineClass of 2005
Certifications & Licensure
MI State Medical License 2009 - 2025
OH State Medical License 2005 - 2009- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 42 citationsProstaglandin E2 As an Inhibitory Modulator of Fibrogenesis in Human Lung AllograftsN.M. Walker, Linda Badri, Anish Wadhwa, Scott H. Wettlaufer, Marc Peters-Golden
American Journal of Respiratory and Critical Care Medicine. 2012-12-14 - 53 citationsMesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndromeLinda Badri, Susan Murray, Lyrica X. Liu, N.M. Walker, Andrew Flint
American Journal of Respiratory and Critical Care Medicine. 2011-04-15 - 2 citationsAcute rejection in a highly sensitized lung transplant recipient with pre-formed donor-directed anti-HLA class II antibodies: role of bortezomib therapy.Linda J. Stuckey, Malek Kamoun, Anish Wadhwa, Millie Samaniego, C.E. Bartos
Clinical Transplants. 2009-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
